<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MetaboNet: The Largest Publicly Available Consolidated Dataset for Type 1 Diabetes Management - Health AI Hub</title>
    <meta name="description" content="This paper introduces MetaboNet, the largest publicly available consolidated dataset designed to overcome the fragmentation and lack of standardization in exist">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>MetaboNet: The Largest Publicly Available Consolidated Dataset for Type 1 Diabetes Management</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2601.11505v1" target="_blank">2601.11505v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2026-01-16
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Miriam K. Wolff, Peter Calhoun, Eleonora Maria Aiello, Yao Qin, Sam F. Royston
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cs.AI, eess.SY, q-bio.QM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2601.11505v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2601.11505v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces MetaboNet, the largest publicly available consolidated dataset designed to overcome the fragmentation and lack of standardization in existing Type 1 Diabetes (T1D) management datasets. By unifying continuous glucose monitoring (CGM) and insulin pump data from 3135 subjects, MetaboNet aims to facilitate the development of more generalizable and comparable T1D algorithms.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>MetaboNet provides a crucial standardized and large-scale data resource for Type 1 Diabetes research, directly supporting the development of advanced algorithms for personalized insulin management, glucose prediction, and automated delivery systems, ultimately improving patient outcomes and reducing disease complications.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The MetaboNet dataset serves as a foundational resource for developing and evaluating machine learning and AI algorithms in Type 1 Diabetes management. Potential applications include predictive modeling for glucose levels, optimization of insulin delivery systems (e.g., automated insulin delivery or 'artificial pancreas' systems), identification of personalized treatment strategies, and real-time decision support tools for patients and clinicians.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical limitation of fragmented, non-standardized, and difficult-to-access T1D datasets, which impede algorithmic development and comparability.</li>
                    
                    <li>MetaboNet is a consolidated data resource comprising 3135 subjects and 1228 patient-years of overlapping CGM and insulin pump data, making it substantially larger than previous standalone benchmarks.</li>
                    
                    <li>Inclusion criteria for data consolidation required the availability of both continuous glucose monitoring (CGM) data and corresponding insulin pump dosing records.</li>
                    
                    <li>Auxiliary information such as reported carbohydrate intake and physical activity was retained when present to enrich the dataset.</li>
                    
                    <li>The resource is distributed via a fully public subset available for immediate download at https://metabo-net.org/, and a Data Use Agreement (DUA)-restricted subset accessible through application processes.</li>
                    
                    <li>For DUA-restricted datasets, processing pipelines are provided to automatically convert the data into the standardized MetaboNet format.</li>
                    
                    <li>The consolidated dataset covers a broad range of glycemic profiles and demographics, enabling the development of more generalizable and robust T1D management algorithms.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The authors consolidated multiple existing publicly available Type 1 Diabetes datasets. The core methodology involved standardizing the data structure and requiring the presence of both continuous glucose monitoring (CGM) data and corresponding insulin pump dosing records for inclusion. Auxiliary information like carbohydrate intake and physical activity was integrated where available. Processing pipelines are supplied for DUA-restricted datasets to ensure conversion into the unified MetaboNet format.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The primary finding is the establishment of MetaboNet, the largest publicly available consolidated dataset for T1D management, encompassing 3135 subjects and 1228 patient-years of overlapping CGM and insulin data. This consolidation successfully creates a standardized resource covering diverse glycemic profiles and demographics, which was previously unavailable in a unified form.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>MetaboNet has the potential to significantly accelerate the creation and validation of more accurate, robust, and personalized algorithms for T1D management. This includes advancements in automated insulin delivery (closed-loop systems), improved glucose prediction models, and enhanced clinical decision support tools, leading to better glycemic control, fewer hypoglycemic/hyperglycemic events, and a reduced risk of long-term diabetes complications for patients.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations pertaining to the MetaboNet dataset itself. It primarily focuses on addressing the limitations of prior fragmented and non-standardized T1D datasets.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>MetaboNet is positioned as a foundational resource to enable extensive future research in Type 1 Diabetes algorithm development. It will facilitate the creation of more generalizable machine learning and artificial intelligence models for insulin dosing, glucose prediction, and closed-loop control systems, thereby fostering substantial advancements in T1D management strategies and personalized medicine.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Type 1 Diabetes</span>
                    
                    <span class="tag">Endocrinology</span>
                    
                    <span class="tag">Medical Informatics</span>
                    
                    <span class="tag">Computational Medicine</span>
                    
                    <span class="tag">Biomedical Engineering</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Type 1 Diabetes</span>
                    
                    <span class="tag tag-keyword">Continuous Glucose Monitoring</span>
                    
                    <span class="tag tag-keyword">Insulin Pump</span>
                    
                    <span class="tag tag-keyword">Dataset</span>
                    
                    <span class="tag tag-keyword">Algorithm Development</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                    <span class="tag tag-keyword">Data Standardization</span>
                    
                    <span class="tag tag-keyword">Glycemic Control</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Progress in Type 1 Diabetes (T1D) algorithm development is limited by the fragmentation and lack of standardization across existing T1D management datasets. Current datasets differ substantially in structure and are time-consuming to access and process, which impedes data integration and reduces the comparability and generalizability of algorithmic developments. This work aims to establish a unified and accessible data resource for T1D algorithm development. Multiple publicly available T1D datasets were consolidated into a unified resource, termed the MetaboNet dataset. Inclusion required the availability of both continuous glucose monitoring (CGM) data and corresponding insulin pump dosing records. Additionally, auxiliary information such as reported carbohydrate intake and physical activity was retained when present. The MetaboNet dataset comprises 3135 subjects and 1228 patient-years of overlapping CGM and insulin data, making it substantially larger than existing standalone benchmark datasets. The resource is distributed as a fully public subset available for immediate download at https://metabo-net.org/ , and with a Data Use Agreement (DUA)-restricted subset accessible through their respective application processes. For the datasets in the latter subset, processing pipelines are provided to automatically convert the data into the standardized MetaboNet format. A consolidated public dataset for T1D research is presented, and the access pathways for both its unrestricted and DUA-governed components are described. The resulting dataset covers a broad range of glycemic profiles and demographics and thus can yield more generalizable algorithmic performance than individual datasets.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>22 pages, 5 figures, 7 supplementary figures, submitted to JDST</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>